CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Unsecured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Unsecured Loans | - | - | ₹-332 Cr | ₹40 Cr | ₹847 Cr |
What is the latest Unsecured Loans ratio of CIPLA ?
| Year | Unsecured Loans |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹-332 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹847 Cr |
How is Unsecured Loans of CIPLA Trending?
| Years | Unsecured Loans | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 100.00 | |
| Mar2023 | ₹-332 Cr | Negative | |
| Mar2022 | ₹40 Cr | -95.28 | |
| Mar2021 | ₹847 Cr | - | |
Compare Unsecured Loans of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹107,122.4 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| MANKIND PHARMA | ₹84,468.2 Cr | -0.9% | -2.7% | -13.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.3% |
0.9% |
-8.9% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses